The European REVERT Project: An ai-based dss for treatment selection

In: Open access government, Band 42, Heft 1, S. 122-123

Abstract

The european revert project: an ai-based dss for treatment selection
Find out here about the European REVERT project, an AI-based DSS for treatment selection. The REVERT project is built around predictive medicine and artificial intelligence (AI). The Consortium includes 22 top-performing research, biobanks and clinical centres, as well as four small-medium enterprises (SMEs) from five European countries, whose expertise spans from computer science to biomarker discovery, omics sciences, and clinical oncology settings, with a shared focus on advancing personalised medicine through AI-health research and development.